APM HUMAN SERVICES INTERNATIONAL LIMITED (APM)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
APM - APM HUMAN SERVICES INTERNATIONAL LIMITED
FNArena Sector :
Healthcare
Year End: June
GICS Industry Group : Commercial Services & Supplies
Debt/EBITDA: 3.1
Index: ASX300 | ALL-ORDS
FNArena Sector : Healthcare
Year End: June
GICS Industry Group : Commercial Services & Supplies
Debt/EBITDA: 3.1
LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
---|---|---|---|
$1.18
22 Apr |
0.005 OPEN $1.17 |
0.43% HIGH $1.19 |
888,469 LOW $1.17 |
TARGET | |||||
|
|||||
Franking for last dividend paid out: 100% |
FNARENA'S MARKET CONSENSUS FORECASTS
Title | FY22 Actual |
FY23 Actual |
FY24 Forecast |
FY25 Forecast |
---|---|---|---|---|
EPS (cps) | xxx | N/A | 9.3 | xxx |
DPS (cps) | xxx | N/A | 8.3 | xxx |
EPS Growth | xxx | N/A | N/A | xxx |
DPS Growth | xxx | N/A | N/A | xxx |
PE Ratio | xxx | N/A | 12.7 | xxx |
Dividend Yield | xxx | N/A | 7.0% | xxx |
Div Pay Ratio(%) | xxx | N/A | 88.9% | xxx |
Last ex-div: 07/09 - ex-div 5c (franking 100%)
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2024 FactSet UK Limited. All rights reserved
Title | 2022 | 2023 |
---|---|---|
EPS Basic | xxx | 11.7 |
DPS All | xxx | 10.0 |
Sales/Revenue | xxx | 1,893.8 M |
Book Value Per Share | xxx | 162.5 |
Net Operating Cash Flow | xxx | 153.4 M |
Net Profit Margin | xxx | 5.67 % |
EPS Basic
DPS All
Sales/Revenue
Book Value Per Share
Net Operating Cash Flow
Net Profit Margin
Title | 2022 | 2023 |
---|---|---|
Return on Capital Employed | xxx | 7.24 % |
Return on Invested Capital | xxx | 4.69 % |
Return on Assets | xxx | 3.63 % |
Return on Equity | xxx | 7.24 % |
Return on Total Capital | xxx | 8.16 % |
Free Cash Flow ex dividends | xxx | 43.2 M |
Return on Capital Employed
Return on Invested Capital
Return on Assets
Return on Equity
Return on Total Capital
Free Cash Flow ex dividends
Title | 2022 | 2023 |
---|---|---|
Short-Term Debt | xxx | 65 M |
Long Term Debt | xxx | 963 M |
Total Debt | xxx | 1,028 M |
Goodwill - Gross | xxx | 1,797 M |
Cash & Equivalents - Generic | xxx | 107 M |
Price To Book Value | xxx | 1.30 |
Short-Term Debt
Long Term Debt
Total Debt
Goodwill - Gross
Cash & Equivalents - Generic
Price To Book Value
Title | 2022 | 2023 |
---|---|---|
Capex | xxx | 46.6 M |
Capex % of Sales | xxx | 2.46 % |
Cost of Goods Sold | xxx | 1,486 M |
Selling, General & Admin. Exp & Other | xxx | 216 M |
Research & Development | xxx | - |
Investments - Total | xxx | - |
Capex
Capex % of Sales
Cost of Goods Sold
Selling, General & Admin. Exp & Other
Research & Development
Investments - Total
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
APM STOCK CHART
FNArena News on APM
1 |
Australian Broker Call *Extra* Edition – Apr 11, 2024Apr 11 2024 - Daily Market Reports |
2 |
Australian Broker Call *Extra* Edition – Mar 27, 2024Mar 27 2024 - Daily Market Reports |
3 |
Rudi’s View: CBA, GQG, Pilbara Minerals, Sonic Healthcare, Webjet & XeroMar 14 2024 - Rudi's View |
4 |
FNArena Corporate Results Monitor – 29-02-2024Feb 29 2024 - Australia |
5 |
Rudi’s View: Week 3 – Not As Good, But Not BadFeb 28 2024 - Rudi's View |
Latest Healthcare News
1 |
Dr Boreham’s Crucible: 4D Medical10:00 AM - Small Caps |
2 |
Dr Boreham’s Crucible: Race OncologyApr 09 2024 - Small Caps |
3 |
The Power Of New Weight-Loss DrugsApr 03 2024 - International |
4 |
Dr Boreham’s Crucible: HydrixMar 26 2024 - Small Caps |
5 |
Treasure Chest: Lifestyle Communities En VogueMar 19 2024 - Treasure Chest |
6 |
Uptrend Resumed For ResMedMar 19 2024 - Technicals |
7 |
Capitol Health’s Higher Margin OutlookMar 13 2024 - Small Caps |
8 |
Rudi’s View: Healthcare Under The ScannerMar 13 2024 - Rudi's View |
9 |
Dr Boreham’s Crucible: Neuren PharmaceuticalsMar 11 2024 - Small Caps |
10 |
Dr Boreham’s Crucible: CochlearFeb 28 2024 - Australia |